Literature DB >> 2342244

Activation of complement by hemodialysis membranes: polyacrylonitrile binds more C3a than cuprophan.

A K Cheung1, C J Parker, L A Wilcox, J Janatova.   

Abstract

Conventionally, complement activation by hemodialysis membranes has been determined by measuring fluid phase C3a. Based on such measurements, polyacrylonitrile (PAN) membranes have been classified as weak activators compared to cuprophan. Previous studies have demonstrated, however, that PAN adsorb fluid phase C3a. Based on that observation, we hypothesized that complement activation by PAN might be artifactually underestimated if relatively large amounts of C3a remained membrane bound. In the present study, a method that allows the simultaneous quantification of both fluid phase and membrane bound C3a was used to assess complement activation by PAN and cuprophan. Pieces of membrane were incubated with C3-depleted serum that had been repleted with radiolabeled C3. Subsequently, the supernates and membranes were subjected to SDS-PAGE, and complement activation was quantified by determining the radioactivity of the C3a bands in the gel. The results showed that while the serum exposed to cuprophan membranes contained almost five times more C3a than that exposed to PAN, approximately 80 times more C3a was bound to the PAN membranes. Consequently, the total amount of C3a generated in the presence of PAN was higher than that generated in the presence of cuprophan. We conclude that assessment of complement activation by hemodialysis membranes using fluid phase C3a measurements alone may be misleading.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2342244     DOI: 10.1038/ki.1990.85

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  11 in total

1.  Complement activation and bioincompatibility. The terminal complement complex for evaluation and surface modification with heparin for improvement of biomaterials.

Authors:  T E Mollnes; V Videm; J Riesenfeld; P Garred; J L Svennevig; E Fosse; K Hogasen; M Harboe
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

2.  Proteomic investigations on the effect of different membrane materials on blood protein adsorption during haemodialysis.

Authors:  Andrea Urbani; Vittorio Sirolli; Santina Lupisella; Stefano Levi-Mortera; Barbara Pavone; Luisa Pieroni; Luigi Amoroso; Roberto Di Vito; Sonia Bucci; Sergio Bernardini; Paolo Sacchetta; Mario Bonomini
Journal:  Blood Transfus       Date:  2012-05       Impact factor: 3.443

3.  Ex vivo complement protein adsorption on positively and negatively charged cellulose dialyser membranes.

Authors:  A Mahiout; B M Matata; J Vienken; J M Courtney
Journal:  J Mater Sci Mater Med       Date:  1997-05       Impact factor: 3.896

4.  Application of a hemolysis assay for analysis of complement activation by perfluorocarbon nanoparticles.

Authors:  Christine T N Pham; Dennis G Thomas; Julia Beiser; Lynne M Mitchell; Jennifer L Huang; Angana Senpan; Grace Hu; Mae Gordon; Nathan A Baker; Dipanjan Pan; Gregory M Lanza; Dennis E Hourcade
Journal:  Nanomedicine       Date:  2013-11-08       Impact factor: 5.307

Review 5.  Reconsidering adsorption in hemodialysis: is it just an epiphenomenon? A narrative review.

Authors:  Nans Florens; Fitsum Guebre-Egziabher; L Juillard
Journal:  J Nephrol       Date:  2021-04-10       Impact factor: 3.902

6.  The immunological effects of continuous veno-venous haemodiafiltration in critically ill patients.

Authors: 
Journal:  Crit Care       Date:  1999       Impact factor: 9.097

7.  An analysis of functional activity via the three complement pathways during hemodialysis sessions: a new insight into the association between the lectin pathway and C5 activation.

Authors:  Hiroyuki Inoshita; Isao Ohsawa; Kisara Onda; Mariko Tamano; Satoshi Horikoshi; Hiroyuki Ohi; Yasuhiko Tomino
Journal:  Clin Kidney J       Date:  2012-10

8.  NLRP3 inflammasome activation in dialyzed chronic kidney disease patients.

Authors:  Simona Granata; Valentina Masola; Elisa Zoratti; Maria Teresa Scupoli; Anna Baruzzi; Michele Messa; Fabio Sallustio; Loreto Gesualdo; Antonio Lupo; Gianluigi Zaza
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

Review 9.  Proteomic Investigations into Hemodialysis Therapy.

Authors:  Mario Bonomini; Vittorio Sirolli; Luisa Pieroni; Paolo Felaco; Luigi Amoroso; Andrea Urbani
Journal:  Int J Mol Sci       Date:  2015-12-10       Impact factor: 5.923

10.  A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients.

Authors:  Gianluigi Zaza; Simona Granata; Federica Rascio; Paola Pontrelli; Maria Pia Dell'Oglio; Sharon Natasha Cox; Giovanni Pertosa; Giuseppe Grandaliano; Antonio Lupo
Journal:  BMC Med Genomics       Date:  2013-05-10       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.